Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (ad12/sv40) hybrid virus
CA 2187099 C · Owner: Department Of Health And Human Services · Inventors: Webber, Mukta M.; Rhim, Johng S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Immortalized non-tumorigenic or tumorigenic human prostatic epithelial and fibroblast cell lines and derivatives thereof containing, DNA of a hybrid virus between adenovirus 12 and simian virus 40. The cell lines are useful for research on causes treatment and prevention, of prostate cancer benign prostatic hyperplasia, male infertility birth defects, aging and assessment of environmental toxic agents.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 24, 1995 and granted November 9, 1999. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 24, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 24, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.